doi: 10.1007/s10147-010-0090-5.
Epub 2010 May 27.
Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects
Affiliations
- PMID: 20505970
- DOI: 10.1007/s10147-010-0090-5
Item in Clipboard
Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects
Int J Clin Oncol.
2010 Jun.
No abstract available
Similar articles
-
Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science.Int J Clin Oncol. 2010 Jun;15(3):235-41. doi: 10.1007/s10147-010-0083-4. Epub 2010 May 27. Int J Clin Oncol. 2010. PMID: 20505971 Review.
-
Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice.Int J Clin Oncol. 2010 Jun;15(3):242-55. doi: 10.1007/s10147-010-0089-y. Epub 2010 May 28. Int J Clin Oncol. 2010. PMID: 20509038 Review.
-
Angiogenesis blockade as therapy for hepatocellular carcinoma: progress and challenges.J Gastroenterol Hepatol. 2011 Jan;26(1):4-6. doi: 10.1111/j.1440-1746.2010.06590.x. J Gastroenterol Hepatol. 2011. PMID: 21175786 No abstract available.
-
Targeting vessels to treat hepatocellular carcinoma.Clin Sci (Lond). 2008 Apr;114(7):467-77. doi: 10.1042/CS20070310. Clin Sci (Lond). 2008. PMID: 18302534 Review.
-
[Molecular structure and abnormal expression of angiopoietin-2 and antiangiogenic targeting therapy of hepatocelluar carcinoma].Zhonghua Gan Zang Bing Za Zhi. 2009 May;17(5):398-400. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19497214 Review. Chinese. No abstract available.
Cited by
-
Identification of target genes of cediranib in alveolar soft part sarcoma using a gene microarray.Oncol Lett. 2017 Apr;13(4):2623-2630. doi: 10.3892/ol.2017.5779. Epub 2017 Feb 24. Oncol Lett. 2017. PMID: 28454442 Free PMC article.
References
-
- N Engl J Med. 1999 Mar 11;340(10):798-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
